VEICHI(SH:688698)2022-10-27 16:00Financial Performance - The company's operating revenue for Q3 2022 was ¥225,200,762.18, representing an increase of 11.78% compared to the same period last year[6]. - The net profit attributable to shareholders for Q3 2022 was ¥35,831,317.01, reflecting a growth of 3.93% year-over-year[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥35,903,721.54, which is an increase of 27.92% compared to the previous year[6]. - The company achieved operating revenue of RMB 665.60 million for the first nine months of 2022, representing a year-on-year growth of 8.07%[23]. - Total operating revenue for the first three quarters of 2022 reached ¥665,601,475.52, an increase of 8.06% compared to ¥615,911,161.47 in the same period of 2021[34]. - The net profit for the third quarter of 2022 was ¥114,702,219.92, compared to ¥100,477,556.45 in the same quarter of 2021, representing a growth of 14.83%[38]. - The net profit for the first three quarters of 2022 was ¥115,508,508.72, up 15.4% from ¥100,077,429.45 in the previous year[58]. Research and Development - Research and development expenses totaled ¥25,618,760.52 for Q3 2022, marking a 34.88% increase year-over-year[8]. - R&D expenses accounted for 11.38% of operating revenue, up by 1.95 percentage points from the previous year[8]. - Research and development expenses reached RMB 67.26 million, a 30.37% increase year-on-year, with R&D personnel comprising 32.83% of the total workforce[24]. - Research and development expenses for the third quarter of 2022 amounted to ¥67,259,499.96, an increase of 30.38% from ¥51,592,644.77 in the previous year[38]. - Research and development expenses for the first three quarters of 2022 were ¥65,651,014.31, compared to ¥50,682,342.39 in the same period of 2021, marking a 29.5% increase[55]. - The company plans to continue investing in R&D to maintain its technological leadership and actively pursue new product development and process upgrades[12]. - The company plans to enhance its technological leadership by increasing investment in R&D and actively developing new products and process upgrades[24]. - The company added 25 new patents during the reporting period, bringing the total number of valid patents to 143[24]. Assets and Liabilities - The total assets at the end of Q3 2022 were ¥1,348,415,265.44, a 6.30% increase from the end of the previous year[8]. - The total assets as of the end of the third quarter of 2022 were ¥1,348,415,265.44, compared to ¥1,268,557,476.93 at the end of the third quarter of 2021, marking a growth of 6.29%[33]. - The total liabilities for the third quarter of 2022 were ¥396,105,741.81, a slight decrease from ¥401,729,045.65 in the same period of 2021[33]. - The total liabilities decreased slightly to ¥395,813,513.17 from ¥401,378,614.92, indicating a reduction of about 1.4%[53]. - The equity attributable to shareholders at the end of Q3 2022 was ¥951,745,290.85, which is a 9.86% increase year-over-year[8]. - The equity attributable to shareholders of the parent company increased to ¥951,745,290.85 from ¥866,325,597.34 year-on-year, reflecting a growth of 9.87%[33]. - The company's total equity increased to ¥954,714,479.68, up from ¥868,404,747.55, reflecting a growth of approximately 9.9%[53]. Cash Flow - The cash flow from operating activities for the year-to-date was ¥64,744,333.45, with a significant increase attributed to a 149.19% growth in overseas business volume[12]. - Cash flow from operating activities generated a net cash inflow of CNY 64,744,333.45, compared to a net outflow of CNY 12,171,854.54 in the previous period[45]. - Cash received from the sale of goods and services was CNY 400,316,274.70, up from CNY 273,174,915.04, indicating a growth of approximately 46.5%[42]. - The company's cash received from operating activities totaled ¥437,936,583.53, compared to ¥299,198,923.31 in the previous year, representing a growth of 46.5%[60]. - The company reported a significant increase in cash flow from investment activities, with cash inflows of CNY 635,682,385.95 compared to CNY 443,936,855.21 in the previous period, marking a growth of about 43.2%[45]. - The ending balance of cash and cash equivalents was $126.91 million, up from $86.16 million year-over-year[63]. Market Presence - The company has a strategic focus on expanding its overseas market presence, as evidenced by the significant growth in overseas revenue[23]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[43].